The most promising compound in this series for the development of a KOR agonist/MOR partial agonist for treatment of cocaine addiction, analogue 8b, shows high potency and efficacy at KOR, high potency and low efficacy at MOR, and is devoid of DOR agonism. Here, OPRM1 is linked to cocaine dependence.